Recent Quarter Total Invested
$647.39 M
Recent Quarter Institutional Ownership Percentage
67.03%
Total Invested of Last Quarter
$618.58 M
Ownership Percentage of Last Quarter
80.01%
Autolus Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 24.22 M | $87.92 M | 35.39% | 9.10% |
| BLACKSTONE INC. | 11/14/2024 | 20.49 M | $74.36 M | 0.00% | 7.70% |
| SYNCONA PORTFOLIO LTD | 11/14/2024 | 18.55 M | $67.35 M | -13.08% | 6.97% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 15.27 M | $55.44 M | 0.00% | 5.74% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 12.35 M | $44.81 M | 0.00% | 4.64% |
| TFG ASSET MANAGEMENT GP LTD | 11/14/2024 | 8.00 M | $29.04 M | 0.00% | 3.01% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 6.87 M | $24.95 M | 9.95% | 2.58% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 4.62 M | $16.78 M | 0.00% | 1.74% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 4.50 M | $16.34 M | 4.65% | 1.69% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.43 M | $16.07 M | 100.00% | 1.66% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.84 M | $13.95 M | -12.97% | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 3.64 M | $13.21 M | 0.00% | 1.37% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 3.19 M | $11.58 M | -12.52% | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.95 M | $10.71 M | -7.81% | 1.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 2.86 M | $10.40 M | 16.83% | 1.08% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 2.81 M | $10.21 B | -18.30% | 1.06% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 2.62 M | $9.50 M | -1.73% | 0.98% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 1.83 M | $6.64 M | -27.70% | 0.69% |
| MORGAN STANLEY | 11/14/2024 | 1.82 M | $6.60 M | -37.42% | 0.68% |
| PERPETUAL LTD | 10/09/2024 | 1.60 M | $5.81 M | -33.38% | 0.60% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.28 M | $4.66 M | 145.31% | 0.48% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 1.06 M | $3.86 M | -10.61% | 0.40% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.03 M | $3.75 M | 0.00% | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 862,804 | $3.13 M | 6.12% | 0.32% |
| MARSHALL WACE, LLP | 11/14/2024 | 757,535 | $2.75 M | 0.00% | 0.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 732,282 | $2.66 M | -27.20% | 0.28% |
| ALPHABET INC. | 11/08/2024 | 698,262 | $2.53 M | 0.00% | 0.26% |
| STATE STREET CORP | 11/14/2024 | 606,544 | $2.20 M | 1.74% | 0.23% |
| HIGHVISTA STRATEGIES LLC | 11/14/2024 | 533,024 | $1.93 M | 2.74% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 486,667 | $1.77 M | 40.38% | 0.18% |
| HEALTHINVEST PARTNERS AB | 11/12/2024 | 442,423 | $1.61 M | 95.64% | 0.17% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 406,558 | $1.48 M | -33.45% | 0.15% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 385,873 | $1.40 M | 1.46% | 0.15% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 364,995 | $1.32 M | -54.49% | 0.14% |
| MAI CAPITAL MANAGEMENT | 11/07/2024 | 329,239 | $1.20 M | -1.43% | 0.12% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 318,000 | $1.15 M | 23.88% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 303,008 | $1.10 M | -42.37% | 0.11% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 298,086 | $1.08 M | 100.00% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 267,040 | $969,355 | 5.34% | 0.10% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 250,871 | $910,662 | -78.09% | 0.09% |
| VONTOBEL HOLDING LTD. | 10/16/2024 | 200,941 | $729,416 | -2.97% | 0.08% |
| 11/14/2024 | 195,000 | $707.85 M | 100.00% | 0.07% | |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 185,639 | $673,870 | 15.56% | 0.07% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 176,000 | $638,880 | 0.00% | 0.07% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 164,921 | $598,663 | 0.14% | 0.06% |
| UBS GROUP AG | 11/14/2024 | 156,978 | $569,830 | 15.60% | 0.06% |
| CETERA INVESTMENT ADVISERS | 11/13/2024 | 132,000 | $479,160 | -1.86% | 0.05% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 121,035 | $439,357 | -18.54% | 0.05% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 98,406 | $357,214 | -52.47% | 0.04% |
| CLEARSTEAD ADVISORS, LLC | 11/13/2024 | 96,107 | $348,869 | 0.00% | 0.04% |
Autolus Therapeutics plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AUTL shares?
During the previous two years, 122 institutional investors and hedge funds held shares of Autolus Therapeutics plc. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 24.22 M
Blackstone Inc.: 20.49 M
Syncona Portfolio Ltd: 18.55 M
Deep Track Capital, LP: 15.27 M
Avoro Capital Advisors LLC: 12.35 M
TFG Asset Management GP Ltd: 8 M
-
What percentage of Autolus Therapeutics plc stock is owned by institutional investors?
67.03% of Autolus Therapeutics plc stock is owned by institutional investors.
-
How much institutional buying is happening at AUTL ?
Institutional investors have bought a total of 171.35 M shares in the last 24 months. This purchase volume represents approximately $503.77 M in transactions.